<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03787355</url>
  </required_header>
  <id_info>
    <org_study_id>PERIO7:4:85</org_study_id>
    <nct_id>NCT03787355</nct_id>
  </id_info>
  <brief_title>Clinical Evaluation of Vertical Inter-implant Papilla Height in Platform Matched Implants in Comparison to Morse Connection Abutments</brief_title>
  <official_title>Clinical Evaluation of Vertical Inter-implant Papilla Height in Platform Matched Implants in Comparison to Morse Connection Abutments: A Randomized Controlled Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The complete fill of the inter-implant mucosa is much more challenging between two implants,&#xD;
      than single implants, and is considered to be unpredictable (Tymstra et al., 2011). However,&#xD;
      previous clinical studies have pointed to a relationship between the inter-implant mucosa&#xD;
      fill and the horizontal distance between two adjacent implants. In particular, a greater&#xD;
      inter-implant bone loss and the absence of the inter-implant mucosa were noted when&#xD;
      neighboring implants were not separated by more than 3 mm (Tarnow, Magner and Fletcher,&#xD;
      1992).&#xD;
&#xD;
      The implant-abutment connection may have an impact on the amount such inter-implant bone&#xD;
      loss, with morse-taper (MT) abutments emerging from the central region of the implant allow&#xD;
      additional thickness in the horizontal soft-tissue component. This might help reducing&#xD;
      marginal bone remodeling during biological width formation. Moreover, the literature&#xD;
      indicates that the peri-implant bone strain vary significantly with the type of&#xD;
      implant-abutment connection. The conical interface of MT connections helps dissipating the&#xD;
      forces to the fixture.&#xD;
&#xD;
      The aim of the study is to clinically investigate the fate of soft tissue and papilla&#xD;
      following crown placement on neighboring morse cone implants versus non-platform switched&#xD;
      implants denoting the fate of soft tissue and papilla.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      -  Study is to be conducted in the Oral Medicine and Periodontology department, Faculty of&#xD;
           Oral and Dental Medicine - Cairo University, Egypt.&#xD;
&#xD;
        -  Patients are to be selected from the outpatient clinic of the department of Oral&#xD;
           Medicine and Periodontology-Cairo University.&#xD;
&#xD;
      Intervention:&#xD;
&#xD;
      Clinical examination:&#xD;
&#xD;
        1. Evaluation of the patient's general condition of the oral cavity, to make sure it&#xD;
           complies with the criteria required to be enrolled in the study in terms of oral&#xD;
           hygiene, pathological conditions, occlusion and inter-arch space.&#xD;
&#xD;
        2. Evaluation of the periapical condition and crestal bone level using a periapical&#xD;
           radiograph.&#xD;
&#xD;
        3. Evaluation of the soft tissue biotype by trans-gingival piercing using a periodontal&#xD;
           probe.&#xD;
&#xD;
        4. Width of keratinized gingiva (measured by a periodontal probe from the gingival margin&#xD;
           to the mucogingival junction). It is measured at three areas (mesial, midbuccal and&#xD;
           distal).&#xD;
&#xD;
      SURGICAL PROTOCOL (T0):&#xD;
&#xD;
        -  Patients meeting the inclusion criteria, CBCT analysis and extensive diagnosis is done&#xD;
           to plan for treatment.&#xD;
&#xD;
        -  After randomization patients are assigned to one of the two groups&#xD;
&#xD;
        -  After profound anesthesia administration, a full thickness crestal flap is reflected,&#xD;
           sequential osteotomy of the implant sites to the desired depth is performed with great&#xD;
           care of interimplant distance maintenance to a 3-4mm.&#xD;
&#xD;
        -  Implant insertion and confirmatory x-rays are performed.&#xD;
&#xD;
        -  Gingival formers will be placed.&#xD;
&#xD;
        -  Flap closure is performed with interrupted 4-0 polyproplene sutures.&#xD;
&#xD;
      Postoperative Care:&#xD;
&#xD;
      Postoperative medication -Administration of:&#xD;
&#xD;
        1. Anti-inflammatory drugs (NSAIDS; Ibuprofen 600mg three times daily for 5 days)&#xD;
           (Francesco Pieri et al, 2012).&#xD;
&#xD;
        2. Antiseptic mouth rinse (0.12% Chlorhexidine oral rinse) will be prescribed starting from&#xD;
           the second day for 60 seconds two times a day for 14 days (Jun Yu et al, 2015).&#xD;
&#xD;
           -Patient self-care instructions:&#xD;
&#xD;
        3. Application of an ice bag to the treated area for the first 24 hours (Francesco Pieri et&#xD;
           al, 2012).&#xD;
&#xD;
        4. The patients were instructed to gently brush the operated area starting from the second&#xD;
           day with a soft brush using roll technique.&#xD;
&#xD;
      Scheduled time of re-entry for patients:&#xD;
&#xD;
      3 months for prosthesis fabrication.&#xD;
&#xD;
      Clinical Examinations:&#xD;
&#xD;
      At the 3-month (T1), 6-month (T2) and 12-month (T3), the following clinical parameters will&#xD;
      be recorded at the implant sites: Interimplant vertical papilla height, pink esthestic score&#xD;
      (PES), probing depth (PD), peri-implant mucosal height (PMH), bleeding on probing at six&#xD;
      sites of each implant (mesiobuccal, buccal, distobuccal, distolingual, lingual, and&#xD;
      mesiolingual), and width of buccal keratinized mucosa (KM) at the midbuccal surface of each&#xD;
      implant.&#xD;
&#xD;
      KM will be recorded as the linear distance from the mucosal margin to the mucogingival line.&#xD;
&#xD;
      Radiographic Examination Radiographic examination will be performed immediately after the&#xD;
      surgical procedure (T0), and at T1 and T3. Standard periapical radiographs will be taken&#xD;
      using a digital imaging software system.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 17, 2019</start_date>
  <completion_date type="Anticipated">January 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Intervention versus Control.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vertical papilla height</measure>
    <time_frame>6,12 months from T0 (Implant insertion)</time_frame>
    <description>Change will be measured using periodontal probe in millimeters,</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pink esthetic score (PES)</measure>
    <time_frame>12 months from T0 (Implant insertion)</time_frame>
    <description>Numerical Rating Score (Fürhauser et al, 2005)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Crestal bone resorption</measure>
    <time_frame>T0 at the time of implant insertion, T1 at 3 months after implant insertion and at T3 at 12 months after implant insertion.</time_frame>
    <description>Using digital X-ray, bone resorption will be measured using a software in mm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Probing depth (PD)</measure>
    <time_frame>3, 6,12 months from T0 (Implant insertion)</time_frame>
    <description>six sites of each implant (mesiobuccal, buccal, distobuccal, distolingual, lingual, and mesiolingual)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Bleeding on probing (BOP)</measure>
    <time_frame>at T2 (6 months after implant insertion) and T3 (12 months after Implant Insertion).</time_frame>
    <description>Binary, Using periodontal probe.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Width of buccal keratinized mucosa (KM)</measure>
    <time_frame>3, 6,12 months from T0 (Implant insertion)</time_frame>
    <description>Measured at the midbuccal surface of each implant using periodontal probe in mm.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction (cleaning, food impaction)</measure>
    <time_frame>At T2 (6 months after implant insertion) and T3 (12 months after Implant Insertion).</time_frame>
    <description>Measured using Numerical Rating Scale (NRS) (Kiyak et al, 1984)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Interimplant Mucosa</condition>
  <arm_group>
    <arm_group_label>Cone Morse Connection Implants</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>2 neighboring Morse connection Implants</description>
  </arm_group>
  <arm_group>
    <arm_group_label>platform matched implants</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>2 neighboring platform matched implants.</description>
  </arm_group>
  <intervention>
    <intervention_type>Combination Product</intervention_type>
    <intervention_name>Morse connection Implants</intervention_name>
    <description>2 neighboring morse connection Implants of Zinedent - Strauman</description>
    <arm_group_label>Cone Morse Connection Implants</arm_group_label>
    <arm_group_label>platform matched implants</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Systemically healthy patients.&#xD;
&#xD;
          -  Good oral hygiene.&#xD;
&#xD;
          -  Missing minimum of two neighboring maxillary teeth with sufficient bucco-palatal bone&#xD;
             of ≥ 6mm.&#xD;
&#xD;
          -  Interimplant distance planned to be 3-4 mm.&#xD;
&#xD;
          -  Patient acceptance of more than one year of follow up.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Vertically deficient ridges. (≤10 mm)&#xD;
&#xD;
          -  Smokers.&#xD;
&#xD;
          -  Pregnant females.&#xD;
&#xD;
          -  Thin biotype&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Nada Zazou, Masters</last_name>
    <phone>02-01224016945</phone>
    <email>drzazou@hotmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>12613</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nada Zazou, Masters</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 21, 2018</study_first_submitted>
  <study_first_submitted_qc>December 23, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">December 26, 2018</study_first_posted>
  <last_update_submitted>September 13, 2021</last_update_submitted>
  <last_update_submitted_qc>September 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Nada Zazou</investigator_full_name>
    <investigator_title>Principle Investigator, assistant Lecturer, Modern Sciences and Arts University (MSA).</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

